| Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spot (NCT02742285) | Thierry Buclin | 2016-05-01 |
| Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar (NCT02721186) | Ulrika Morris | 2016-04-30 |
| Immune Dysfunction in Newborn Sepsis (NCT03780712) | BioMérieux | 2016-04-17 |
| Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection (NCT02692963) | Radboud University Medical Center | 2016-04-01 |
| Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi (NCT02721420) | Kamuzu University of Health Sciences | 2016-03-24 |
| Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM) (NCT02394522) | University of Notre Dame | 2016-03-01 |
| Clinical Evaluation of the Use of an mHealth Intervention on Quality of Care (NCT03874143) | World Vision Canada | 2016-03-01 |
| Integrated Community Case Management Study in Eastern Province, Zambia (NCT02866097) | Zambia Center for Applied Health Research and Development | 2016-03-01 |
| Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (NCT02694874) | Centro de Investigacao em Saude de Manhica | 2016-02-01 |
| Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration (NCT02654912) | PATH | 2016-02-01 |
| Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia (NCT02610400) | University of California, San Francisco | 2016-02-01 |
| Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania (NCT02294214) | University of Notre Dame | 2016-02-01 |
| Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly (NCT01785979) | Lihir Medical Centre | 2016-01-01 |
| Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults (NCT02658253) | Institut National de la Santé Et de la Recherche Médicale, France | 2016-01-01 |
| PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults (NCT02601716) | Sanaria Inc. | 2016-01-01 |
| Malaria Elimination Pilot Study in Military Forces in Cambodia (NCT02653898) | Armed Forces Research Institute of Medical Sciences, Thailand | 2016-01-01 |
| Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali (NCT02627456) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-12-09 |
| A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B (NCT02600975) | University of Oxford | 2015-12-08 |
| Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil (NCT02600767) | Centers for Disease Control and Prevention | 2015-12-01 |
| Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia (NCT02654730) | London School of Hygiene and Tropical Medicine | 2015-12-01 |
| Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants (NCT02613520) | Sanaria Inc. | 2015-12-01 |
| The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania (NCT02533336) | National Institute for Medical Research, Tanzania | 2015-11-09 |
| A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan (NCT02592408) | Menzies School of Health Research | 2015-11-01 |
| Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique (NCT02914145) | Centro de Investigacao em Saude de Manhica | 2015-11-01 |
| A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1 (NCT02572388) | University of Oxford | 2015-10-15 |
| A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313 (NCT02532049) | University of Oxford | 2015-10-12 |
| A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine (NCT02374450) | GlaxoSmithKline | 2015-10-05 |
| Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria (NCT02411994) | Royal Tropical Institute | 2015-10-01 |
| A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (NCT02573857) | Medicines for Malaria Venture | 2015-10-01 |
| Artemisinin Resistance In Malaria Treated With IV Artesunate (NCT02640495) | University of Oxford | 2015-10-01 |
| Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense) (NCT02672228) | London School of Hygiene and Tropical Medicine | 2015-10-01 |
| Targeted Indoor Residual Spraying Against Malaria (NCT02556242) | London School of Hygiene and Tropical Medicine | 2015-10-01 |
| A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers (NCT02554799) | Medicines for Malaria Venture | 2015-09-17 |
| Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults (NCT02544048) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-04 |
| Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts (NCT02536222) | PATH | 2015-09-01 |
| Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns (NCT02605720) | Lihir Medical Centre | 2015-09-01 |
| Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland (NCT02315690) | University of California, San Francisco | 2015-09-01 |
| A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients (NCT02527005) | University of Ibadan | 2015-09-01 |
| Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria (NCT04897919) | Bandim Health Project | 2015-08-01 |
| Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali (NCT02535767) | University of California, San Francisco | 2015-08-01 |
| A Comparison of Diagnostic Approaches for Malaria and Pneumonia (NCT02482116) | University of Nottingham | 2015-08-01 |
| Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates (NCT02471378) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-28 |
| Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children (NCT02504918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-21 |
| Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... (NCT02511054) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-21 |
| Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria (NCT02492178) | University of Oxford | 2015-07-01 |
| Hati Salama (Secure Voucher) (NCT02561624) | Queen's University | 2015-07-01 |
| Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2) (NCT02461628) | Duke University | 2015-07-01 |
| Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study (NCT02509481) | Colorado State University | 2015-06-01 |
| Dolutegravir Interactions With Artemisinin-based Combination Therapies (NCT02242799) | University of Liverpool | 2015-06-01 |
| Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia (NCT02294188) | University of Notre Dame | 2015-05-01 |
| Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence (NCT02392832) | University of California, Irvine | 2015-04-01 |
| Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent (NCT02431650) | Medicines for Malaria Venture | 2015-04-01 |
| Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets (NCT02387580) | Medicines for Malaria Venture | 2015-04-01 |
| Experimental Falciparum Transmission to Anopheles (NCT02431637) | Medicines for Malaria Venture | 2015-04-01 |
| The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria (NCT02758353) | JSI Research & Training Institute, Inc. | 2015-04-01 |
| Malawi International Center of Excellence in Malaria Research School-based Cohort (NCT04858087) | University of Maryland, Baltimore | 2015-03-24 |
| Spirulina Supplementation and Infant Growth, Morbidity and Motor Development (NCT03523182) | Programme Against Malnutrition | 2015-03-01 |
| Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults (NCT02418962) | Sanaria Inc. | 2015-03-01 |
| Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health Teams (NCT02374580) | George Washington University | 2015-02-01 |
| A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (NCT02389348) | Medicines for Malaria Venture | 2015-02-01 |
| Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali (NCT02334462) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-07 |
| Evaluating the Role of Chloroquine for Malaria Elimination (NCT02698748) | Centro de Investigacao em Saude de Manhica | 2015-01-01 |
| Text Message Reminders to Health Workers on Malaria, Pneumonia, and Diarrhea Case Management in Malawi (NCT02645513) | Centers for Disease Control and Prevention | 2015-01-01 |
| Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic (NCT02708199) | Department of Medical Research, Lower Myanmar | 2015-01-01 |
| Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) (NCT02282293) | University of California, San Francisco | 2014-12-09 |
| The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia (NCT02297477) | Armed Forces Research Institute of Medical Sciences, Thailand | 2014-12-01 |
| Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes (NCT02313376) | Seattle Children's Hospital | 2014-12-01 |
| Providers' Compliance to Malaria Treatment (NCT02298140) | Ifakara Health Institute | 2014-11-01 |
| Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa (NCT02251704) | GlaxoSmithKline | 2014-10-22 |
| Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection (NCT02098590) | Radboud University Medical Center | 2014-10-01 |
| Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria (NCT02528279) | Albert Schweitzer Hospital | 2014-10-01 |
| Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission (NCT02259426) | London School of Hygiene and Tropical Medicine | 2014-10-01 |
| Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM) (NCT02174900) | London School of Hygiene and Tropical Medicine | 2014-10-01 |
| Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana (NCT02903706) | Centre Hospitalier de Cayenne | 2014-10-01 |
| An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa (NCT02207816) | GlaxoSmithKline | 2014-09-18 |
| Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model (NCT04072302) | Novartis Pharmaceuticals | 2014-09-15 |
| Novel Use Of Hydroxyurea in an African Region With Malaria (NCT01976416) | Indiana University | 2014-09-01 |
| Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia (NCT02329301) | PATH | 2014-09-01 |
| Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product (NCT02288637) | London School of Hygiene and Tropical Medicine | 2014-09-01 |
| Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery (NCT02646410) | University of Bamako | 2014-08-01 |
| Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains (NCT02149550) | Radboud University Medical Center | 2014-08-01 |
| Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax (NCT02083068) | Malaria Vaccine and Drug Development Center | 2014-08-01 |
| A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh (NCT02389374) | Menzies School of Health Research | 2014-08-01 |
| Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults (NCT02174978) | U.S. Army Medical Research and Development Command | 2014-08-01 |
| A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5 (NCT02181088) | University of Oxford | 2014-08-01 |
| Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge (NCT02237586) | Sanaria Inc. | 2014-07-01 |
| Evaluation of Seasonal Malaria Chemoprevention in Kita (NCT02894294) | University of Bamako | 2014-07-01 |
| Iron and Prebiotics Fortification in Kenyan Infants (NCT02118402) | Swiss Federal Institute of Technology | 2014-07-01 |
| Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants (NCT02163447) | Grant Dorsey, M.D, Ph.D. | 2014-06-23 |
| Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (NCT02199977) | Duke University | 2014-06-01 |
| A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses (NCT02215707) | Sanaria Inc. | 2014-06-01 |
| Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis (NCT02080026) | Radboud University Medical Center | 2014-06-01 |
| Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States (NCT02153996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-15 |
| A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children (NCT02211729) | London School of Hygiene and Tropical Medicine | 2014-05-01 |
| Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers (NCT02230579) | Medicines for Malaria Venture | 2014-05-01 |
| In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure (NCT02590627) | National Institute for Medical Research, Tanzania | 2014-05-01 |
| School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi (NCT02213211) | London School of Hygiene and Tropical Medicine | 2014-04-01 |
| Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis (NCT02115516) | Sanaria Inc. | 2014-04-01 |
| Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya (NCT01810731) | Centers for Disease Control and Prevention | 2014-04-01 |
| Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults (NCT02132299) | Sanaria Inc. | 2014-04-01 |